Primary paediatric chest wall tumours necessitating surgical management

N Maistry1, J Durell1, S Wilson1

  • 1Oxford University Hospitals NHS Foundation Trust, UK.

Insights

Biological grafts are effective for paediatric chest wall reconstruction after tumor removal. A multidisciplinary team approach is crucial for managing these rare pediatric cancers, ensuring no recurrences or complications.

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Thoracic Surgery

Background:

  • Limited literature exists on oncological chest wall reconstruction in children.
  • Biological grafts are increasingly used in adult procedures but rarely in pediatric cases.
  • This study addresses the need for evidence in pediatric chest wall tumor management.

Purpose of the Study:

  • To present outcomes of a multidisciplinary approach to pediatric chest wall tumors.
  • To evaluate the use of biological grafts for chest wall reconstruction in pediatric patients.
  • To assess the safety and efficacy of biological grafts in this population.

Main Methods:

  • Retrospective analysis of eight pediatric patients treated for primary chest wall tumors (2010-2018).
  • Patients underwent oncological resection followed by chest wall reconstruction.
  • Seven patients received biological grafts for reconstruction.

Main Results:

  • Tumors included lipoblastomas, Ewing's sarcomas, and other sarcomas.
  • All seven patients reconstructed with biological grafts had successful outcomes.
  • No postoperative mortalities, recurrences, or infection-related complications were observed.

Conclusions:

  • Biological grafts are a viable option for chest wall reconstruction after oncological resection in children.
  • A multidisciplinary team approach is essential for optimal management of pediatric chest wall tumors.
  • This approach ensures favorable outcomes with no need for further interventions.
Abstract

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
764
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
449
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
376
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.0K